Genitourinary Cancers | Specialty

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

Expert Discusses Targeted Combinations in RCC

March 31st 2017

David I. Quinn, PhD, MBBS, discusses the latest advances with targeted agents in renal cell caricinoma, including combination regimens with checkpoint inhibitors.

Frontline Immunotherapy on the Horizon in Bladder Cancer

March 29th 2017

Evan Y. Yu, MD, discusses the current treatment options for patients with metastatic urothelial carcinoma, the unmet needs that still exist in this space, and the possibilities for the future treatment landscape.

Sacituzumab Govitecan Shows Promise in Urothelial Cancer

March 23rd 2017

Scott Tagawa, MD, discusses the latest findings with sacituzumab govitecan in patients with metastatic urothelial cancer.

Evidence Builds for Targeting PD-1/PD-L1 Pathway in Bladder Cancer

March 21st 2017

As the number of tumor types with approved PD-1/PD-L1 pathway inhibitors continues to expand, bladder cancer has become a robust area of development.

Thoughts on Metastatic Kidney Cancer

March 20th 2017

Patient Communication About Adjuvant Therapy for RCC

March 20th 2017

VEGF TKI Therapy in the Adjuvant Setting of RCC

March 20th 2017

Upfront Immunotherapy for Metastatic Kidney Cancer

March 20th 2017

CABOSUN Trial of Upfront Cabozantinib in Metastatic RCC

March 20th 2017

Treatment Beyond Progression for Metastatic RCC

March 20th 2017

Clinical Trials of Post-Progression Therapy for mRCC

March 20th 2017

Metastatic RCC: Decision Trees for Second-Line Therapy

March 20th 2017

Choosing Post-Progression Therapy for Metastatic RCC

March 20th 2017

Defining Progression in Metastatic Kidney Cancer

March 20th 2017

Choosing Frontline Therapy for Metastatic Kidney Cancer

March 20th 2017

Goals of Therapy for Advanced Kidney Cancer

March 20th 2017

Rapidly Evolving Paradigms for Treating Advanced RCC

March 20th 2017

The Future of Bladder Cancer Research

March 16th 2017

Bladder Cancer: Monoclonal Antibodies Under Investigation

March 16th 2017

BCG-Refractory Superficial Bladder Cancer

March 16th 2017